PMID: 40391Aug 1, 1979

Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics

Acta Pharmacologica Et Toxicologica
J B Lassen


Apomorphine (ap) was administered subcutaneously to mice kept in individual cages. Ap elicited an abnormal vertical climbing behaviour. The muscarinomimetics physostigmine and oxotremorine as well as the neuroleptics clozapine and haloperidol inhibited the climbing produced by ap 1 mg/kg. A small inactive dose of physostigmine potentiated the effect of clozapine but not that of haloperidol. The anticholinergic atropine antagonized the effect of physostigmine, oxotremozine, clozapine and haloperidol. The climbing behaviour produced by ap is presumably due to stimulation of dopamine receptors and this effect can be antagonized either by blockade of dopamine receptors or by activation of muscarinic receptors. Some lines of evidence suggest that the ap-inhibitory effect of clozapine may be partly due to a muscarinomimetic effect.



Aug 15, 1978·European Journal of Pharmacology·A J PuechJ R Boissier
May 1, 1976·Journal of Clinical Pharmacology·G Chouinard, L Annable
Apr 1, 1976·European Journal of Pharmacology·A J PuechJ R Boissier
Aug 1, 1976·British Journal of Pharmacology·P B Bradley, A Dray
Jan 11, 1975·Clinical Pharmacology and Therapeutics·M B Bowers
May 1, 1975·Pharmakopsychiatrie, Neuro-Psychopharmakologie·H R BürkiT G White
Sep 1, 1967·The Journal of Pharmacy and Pharmacology·N E AndénT Hökfelt
Sep 1, 1972·The Journal of Pharmacy and Pharmacology·K Fuxe, F Sjöqvist
Jan 1, 1973·Neuropharmacology·A BartoliniE F Domino
Nov 1, 1973·Biochemical Pharmacology·V H Sethy, M H Van Woert
Jun 1, 1967·The American Journal of Psychiatry·C P Chien, A Dimascio
Nov 1, 1976·Journal of Neurochemistry·B Oderfeld-Nowak, J Skangiel-Kramska

Related Concepts

Antipsychotic Effect
Cholinergic Agents
Behavior, Animal
Assay OF Haloperidol
Atropinum, atropine
Antipsychotic Agents

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here